GT Biopharma Inc.(GTBP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GTBP GT Biopharma Inc.

盘前交易 04-10 08:45:06 EDT

0.3903

-0.0144

-3.56%

盘前0.4078

+0.0175+4.48%

08:17 EDT

最高0.4031	最低0.3800	成交量87.90万
今开0.4000	昨收0.4047	日振幅5.71%
总市值1,232万	流通市值1,199万	总股本3,155万
成交额34.25万	换手率2.86%	流通股本3,072万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GTBP","market":"US","secType":"STK","nameCN":"GT Biopharma Inc.","latestPrice":0.3903,"timestamp":1775764800000,"preClose":0.4047,"halted":0,"volume":879027,"hourTrading":{"tag":"盘前","latestPrice":0.4078,"preClose":0.3903,"latestTime":"08:17 EDT","volume":3378,"amount":1340.8161969,"timestamp":1775823460084,"change":0.0175,"changeRate":0.044837,"amplitude":0.07174},"delay":0,"changeRate":-0.03558191252779843,"floatShares":30719100,"shares":31553892,"eps":-6.248395,"marketStatus":"盘前交易","change":-0.0144,"latestTime":"04-10 08:45:06 EDT","open":0.4,"high":0.4031,"low":0.38,"amount":342469.13895675,"amplitude":0.057079,"askPrice":0.4558,"askSize":100,"bidPrice":0.3999,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-6.248395,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1775827800000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":0.3903,"preHourTrading":{"tag":"盘前","latestPrice":0.4078,"preClose":0.3903,"latestTime":"08:17 EDT","volume":3378,"amount":1340.8161969,"timestamp":1775823460084,"change":0.0175,"changeRate":0.044837,"amplitude":0.07174},"postHourTrading":{"tag":"盘后","latestPrice":0.4059,"preClose":0.3903,"latestTime":"18:40 EDT","volume":3944,"amount":1577.9782,"timestamp":1775774418087,"change":0.0156,"changeRate":0.039969,"amplitude":0.039969},"volumeRatio":1.8978987738194844,"impliedVol":2.3584,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/GTBP","defaultTab":"news","newsList":[{"id":"2610408959","title":"Gt Biopharma, Inc.盘中异动 早盘急速跳水5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610408959","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610408959?lang=zh_cn&edition=full","pubTime":"2026-02-11 23:15","pubTimestamp":1770822908,"startTime":"0","endTime":"0","summary":"北京时间2026年02月11日23时15分，Gt Biopharma, Inc.股票出现波动，股价急速下跌5.08%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.75%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211231509a6ef88b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211231509a6ef88b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609349723","title":"Gt Biopharma, Inc.盘中异动 大幅跳水5.40%报0.494美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609349723","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609349723?lang=zh_cn&edition=full","pubTime":"2026-02-04 22:46","pubTimestamp":1770216414,"startTime":"0","endTime":"0","summary":"北京时间2026年02月04日22时46分，Gt Biopharma, Inc.股票出现波动，股价大幅下跌5.40%。截至发稿，该股报0.494美元/股，成交量183.18万股，换手率6.87%，振幅6.67%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204224654a47c5c18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204224654a47c5c18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GTBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161471875","title":"GT Biopharma宣布FDA批准GTB-5550 Trike®新药临床试验申请，该药为靶向B7-H3的自然杀伤细胞衔接器，用于治疗表达B7-H3的实体瘤","url":"https://stock-news.laohu8.com/highlight/detail?id=1161471875","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161471875?lang=zh_cn&edition=full","pubTime":"2026-02-03 21:30","pubTimestamp":1770125417,"startTime":"0","endTime":"0","summary":"GT Biopharma Inc. (GTBP) 宣布，其针对GTB-5550 Trike®的研究性新药（IND）申请已获得美国食品药品监督管理局（FDA）的许可。GTB-5550 Trike®是一种靶向B7-H3的自然杀伤（NK）细胞衔接器，旨在治疗表达B7-H3的实体瘤。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GTBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604916862","title":"Gt Biopharma, Inc.盘中异动 股价大跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604916862","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604916862?lang=zh_cn&edition=full","pubTime":"2026-01-16 22:32","pubTimestamp":1768573941,"startTime":"0","endTime":"0","summary":"北京时间2026年01月16日22时32分，Gt Biopharma, Inc.股票出现异动，股价大幅下挫5.16%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。其相关个股中，Jaguar Health, Inc.、Immunitybio, Inc.、Kala Bio, Inc.涨幅较大，Jaguar Health, Inc.、Biodexa Pharmaceuticals Plc、Genprex, Inc.较为活跃，换手率分别为784.40%、105.56%、9.16%，振幅较大的相关个股有Jaguar Health, Inc.、Immunitybio, Inc.、Iterum Therapeutics Plc，振幅分别为24.85%、8.86%、8.66%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116223221a4cc7365&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116223221a4cc7365&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109401951","title":"GT Biopharma 提交GTB-5550 Trike®新药临床试验申请，该药物为靶向B7-H3的自然杀伤细胞衔接器，用于治疗B7-H3表达实体瘤","url":"https://stock-news.laohu8.com/highlight/detail?id=1109401951","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109401951?lang=zh_cn&edition=full","pubTime":"2026-01-15 21:31","pubTimestamp":1768483888,"startTime":"0","endTime":"0","summary":"GT Biopharma Inc. 已正式提交其候选药物GTB-5550 Trike®的新药临床试验申请。该药物是一种靶向B7-H3的自然杀伤细胞衔接器，旨在用于治疗表达B7-H3的实体瘤癌症。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GTBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171041667","title":"GT Biopharma Inc.截至9月30日持有260万美元现金及现金等价物，资金运营覆盖至2026年第一季度","url":"https://stock-news.laohu8.com/highlight/detail?id=1171041667","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171041667?lang=zh_cn&edition=full","pubTime":"2025-11-14 22:09","pubTimestamp":1763129359,"startTime":"0","endTime":"0","summary":"GT Biopharma Inc.截至9月30日持有260万美元现金及现金等价物，资金运营覆盖至2026年第一季度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GTBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179320283","title":"GT Biopharma Inc.: 预计将在2025年12月底或2026年1月递交Gtb-5550的IND申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1179320283","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179320283?lang=zh_cn&edition=full","pubTime":"2025-11-14 22:09","pubTimestamp":1763129356,"startTime":"0","endTime":"0","summary":"GT Biopharma Inc.: 预计将在2025年12月底或2026年1月递交Gtb-5550的IND申请","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GTBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141227084","title":"GT Biopharma发布Gtb-3650 I期临床试验参与者招募更新，针对复发性或难治性CD33表达血液系统恶性肿瘤患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1141227084","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141227084?lang=zh_cn&edition=full","pubTime":"2025-10-23 21:01","pubTimestamp":1761224479,"startTime":"0","endTime":"0","summary":"GT Biopharma发布Gtb-3650 I期临床试验参与者招募更新，针对复发性或难治性CD33表达血液系统恶性肿瘤患者","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GTBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2577237554","title":"Gt Biopharma, Inc.盘中异动 临近收盘股价大跌5.39%报0.662美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577237554","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577237554?lang=zh_cn&edition=full","pubTime":"2025-10-23 03:59","pubTimestamp":1761163176,"startTime":"0","endTime":"0","summary":"北京时间2025年10月23日03时59分，Gt Biopharma, Inc.股票出现波动，股价急速下跌5.39%。截至发稿，该股报0.662美元/股，成交量50.0898万股，换手率14.08%，振幅7.15%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251023035936973d1506&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251023035936973d1506&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2575488047","title":"Gt Biopharma, Inc.盘中异动 大幅下挫5.56%报0.680美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575488047","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575488047?lang=zh_cn&edition=full","pubTime":"2025-10-15 22:20","pubTimestamp":1760538027,"startTime":"0","endTime":"0","summary":"北京时间2025年10月15日22时20分，Gt Biopharma, Inc.股票出现波动，股价快速跳水5.56%。截至发稿，该股报0.680美元/股，成交量22.8637万股，换手率6.43%，振幅2.79%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251015222028a6baf9da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251015222028a6baf9da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2575252713","title":"Gt Biopharma, Inc.盘中异动 股价大涨5.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575252713","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575252713?lang=zh_cn&edition=full","pubTime":"2025-10-13 23:40","pubTimestamp":1760370021,"startTime":"0","endTime":"0","summary":"北京时间2025年10月13日23时40分，Gt Biopharma, Inc.股票出现波动，股价快速拉升5.90%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251013234022972b876f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251013234022972b876f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517317943","title":"Gt Biopharma, Inc.盘中异动 股价大涨5.96%报2.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517317943","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517317943?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:49","pubTimestamp":1741186177,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时49分，Gt Biopharma, Inc.股票出现异动，股价急速拉升5.96%。截至发稿，该股报2.31美元/股，成交量3079股，换手率0.14%，振幅2.87%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.51%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224937989d49f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305224937989d49f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516670266","title":"Gt Biopharma, Inc.盘中异动 早盘股价大跌6.01%报2.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516670266","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516670266?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:53","pubTimestamp":1741099990,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时53分，Gt Biopharma, Inc.股票出现波动，股价快速跳水6.01%。截至发稿，该股报2.19美元/股，成交量1.4533万股，换手率0.65%，振幅5.28%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030422531096394b51&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030422531096394b51&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516630584","title":"Gt Biopharma, Inc.盘中异动 早盘快速下挫5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516630584","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516630584?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:07","pubTimestamp":1741014462,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时07分，Gt Biopharma, Inc.股票出现异动，股价急速下挫5.88%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303230742a25d4af6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303230742a25d4af6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514385530","title":"Gt Biopharma, Inc.盘中异动 快速跳水6.36%报2.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514385530","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514385530?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:32","pubTimestamp":1740666770,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时32分，Gt Biopharma, Inc.股票出现波动，股价快速跳水6.36%。截至发稿，该股报2.21美元/股，成交量8881股，换手率0.40%，振幅2.54%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223250a2567a54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223250a2567a54&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514859064","title":"Gt Biopharma, Inc.盘中异动 快速下挫16.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514859064","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514859064?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:31","pubTimestamp":1740580304,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时31分，Gt Biopharma, Inc.股票出现异动，股价急速下跌16.18%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223144a254f667&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223144a254f667&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514741857","title":"Gt Biopharma, Inc.盘中异动 股价大跌5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514741857","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514741857?lang=zh_cn&edition=full","pubTime":"2025-02-25 02:00","pubTimestamp":1740420058,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日02时00分，Gt Biopharma, Inc.股票出现波动，股价大幅下挫5.58%。截至发稿，该股报2.03美元/股，成交量9705股，换手率0.43%，振幅5.07%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225020058a2524282&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225020058a2524282&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512348952","title":"Gt Biopharma, Inc.盘中异动 股价大涨7.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512348952","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512348952?lang=zh_cn&edition=full","pubTime":"2025-02-19 23:09","pubTimestamp":1739977744,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日23时09分，Gt Biopharma, Inc.股票出现波动，股价快速拉升7.12%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219230905abd508a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219230905abd508a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512109161","title":"Gt Biopharma, Inc.盘中异动 早盘股价大涨5.88%报2.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512109161","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512109161?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:30","pubTimestamp":1739892610,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时30分，Gt Biopharma, Inc.股票出现波动，股价快速拉升5.88%。截至发稿，该股报2.27美元/股，成交量8756股，换手率0.39%，振幅2.80%。Gt Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。Gt Biopharma, Inc.公司简介：GT Biopharma Inc 是一家临床阶段的生物制药公司，专注于在美国开发和商业化新型免疫肿瘤产品，致力于通过其专有产品平台在各种疾病领域发现、开发和商业化新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182330109627a2ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182330109627a2ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GTBP"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://ir.gtbiopharma.com","stockEarnings":[{"period":"1week","weight":-0.1317},{"period":"1month","weight":-0.0627},{"period":"3month","weight":-0.4235},{"period":"6month","weight":-0.4259},{"period":"1year","weight":-0.8226},{"period":"ytd","weight":-0.5029}],"compareEarnings":[{"period":"1week","weight":0.0367},{"period":"1month","weight":0.004},{"period":"3month","weight":-0.0204},{"period":"6month","weight":0.0412},{"period":"1year","weight":0.2393},{"period":"ytd","weight":-0.0029}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"GT Biopharma, Inc.于1965年在加利福尼亚州注册成立。该公司是一个临床阶段的生物制药公司，专注于专有的三特异性杀手接合器融合蛋白免疫细胞接合器技术平台的新型免疫肿瘤产品的开发和商业化。TriKE可设计用于针对血液恶性肿瘤或实体肿瘤的任何数量的肿瘤抗原，不需要患者特异性定制。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.044525},{"month":2,"riseRate":0.25,"avgChangeRate":-0.158196},{"month":3,"riseRate":0.375,"avgChangeRate":0.014711},{"month":4,"riseRate":0.375,"avgChangeRate":0.020909},{"month":5,"riseRate":0.625,"avgChangeRate":0.082319},{"month":6,"riseRate":0.5,"avgChangeRate":0.017541},{"month":7,"riseRate":0.25,"avgChangeRate":-0.059541},{"month":8,"riseRate":0.125,"avgChangeRate":-0.133669},{"month":9,"riseRate":0.125,"avgChangeRate":-0.164268},{"month":10,"riseRate":0.75,"avgChangeRate":0.054196},{"month":11,"riseRate":0.125,"avgChangeRate":-0.132411},{"month":12,"riseRate":0.375,"avgChangeRate":0.036951}],"exchange":"NASDAQ","name":"GT Biopharma Inc.","nameEN":"GT Biopharma Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GT Biopharma Inc.(GTBP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供GT Biopharma Inc.(GTBP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"GT Biopharma Inc.,GTBP,GT Biopharma Inc.股票,GT Biopharma Inc.股票老虎,GT Biopharma Inc.股票老虎国际,GT Biopharma Inc.行情,GT Biopharma Inc.股票行情,GT Biopharma Inc.股价,GT Biopharma Inc.股市,GT Biopharma Inc.股票价格,GT Biopharma Inc.股票交易,GT Biopharma Inc.股票购买,GT Biopharma Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GT Biopharma Inc.(GTBP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供GT Biopharma Inc.(GTBP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}